Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 7Hereditary Sensory and Autonomic Neuropathies 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Ovarian Neoplasms 2Neoplasm Metastasis 2Rectal Neoplasms 1Neoplasms 1Hyperglycemia 1Exanthema 1Advanced or Metastatic ER+ Breast Cancer 1Advanced Breast Cancer 1

Interventions

benralizumab 1Sirolimus 1Gels 1Fulvestrant 1Fibroblast Growth Factor 7 1Dapsone 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Exanthema × Alpelisib × Clear all
NCT05966584 2024-08-29

A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Terminated
1 enrolled 5 charts
Breast

Breast Neoplasms, Exanthema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡